Artivion (AORT) Asset Writedowns and Impairment (2010 - 2013)
Artivion (AORT) reported Asset Writedowns and Impairment of $3.2 million for Q4 2013, up 841.18% quarter-over-quarter from $340000.0 in Q3 2012.
Artivion (AORT) Asset Writedowns and Impairment (2010 - 2013) Analysis & Trends
Artivion has reported Asset Writedowns and Impairment for 3 years, with the latest figure at $3.2 million in Q4 2013.
- For the quarter ending Q4 2013, Asset Writedowns and Impairment changed N/A year-over-year to $3.2 million; the trailing twelve-month figure through Dec 2013 stood at $4.5 million (changed N/A YoY), and the FY2021 full-year result was $4.9 million, changed N/A from the prior year.
- Asset Writedowns and Impairment for Q4 2013 stood at $3.2 million, up from $340000.0 in the prior quarter.
- The five-year high for Asset Writedowns and Impairment was $3.6 million in Q3 2010, with the low at -$2.7 million in Q4 2010.
- Historically, Asset Writedowns and Impairment has averaged $1.1 million across 3 years, with a median of $1.8 million in 2012.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn |
| 10 | Artivion | 1.02 Bn | 961.48 Mn | 75.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2013 | 3.20 Mn |
| Dec 31, 2013 | 3.20 Mn |
| Sep 30, 2012 | 340,000.00 |
| Sep 30, 2012 | 340,000.00 |
| Dec 31, 2010 | -2.72 Mn |
| Dec 31, 2010 | -2.72 Mn |
| Sep 30, 2010 | 3.64 Mn |
| Sep 30, 2010 | 3.64 Mn |